
Sleep specialist backing RFK Jr.'s MAHA movement pushes to change school start times in America
Washington, D.C. – A sleep expert who is backing Robert F. Kennedy Jr.'s Make America Healthy Again (MAHA) movement is pushing for something he says people aren't talking about enough: sleep.
Jeffrey Rose, a New York-based clinical hypnotist and sleep specialist, is a friend and longtime supporter of Kennedy, who was confirmed by the Senate on Thursday as Health and Human Services (HHS) secretary in President Donald Trump's cabinet.
"[The MAHA] movement means a lot to me because I'm preaching health all the time," said Rose in an interview with Fox News Digital.
Rose said there is chronic sleep deprivation across the country, but more specifically in students.
"These high school kids are not able to be sharp and focus and to learn, it doesn't matter how good the schools are or the teachers or the reputation. Kids are exhausted in school."
Teenagers ages 13 through 17 should sleep 8-to-10 hours per 24 hours, according to the Centers for Disease Control and Prevention (CDC).
"We need to get the kids an opportunity to get nine hours [of] sleep, which is impossible right now," shared Rose.
Rose started the Rockland County, New York, chapter of "Start Schools Later" – an organization made up of clinical professionals working to push back the start times in high schools across the U.S.
"There's no greater reform we can make for high school education," he said.
Rose said lack of sleep in its own way is a "gateway drug" with the side effects spilling into students leaning on relaxants like alcohol and marijuana, and then Adderall or Ritalin to focus.
The most current data from the Youth Risk Behavior Survey (YRBS), developed by the CDC, showed that 77.3% of high school students reported not getting enough sleep on school nights.
"When [schools start later] you get less sickness because people are showing up with strong immune systems, less absenteeism, less car accidents, better sports outcomes, better. Everything is performed much better." said Rose.
"With the exception of Dr. Oz, I haven't heard too many people talking about sleep…I have talked to Bobby [RFK Jr.] about that, and he's listening to that."
"Now that he doesn't have to focus on getting confirmed, I could talk about the issues that are important to us, important to me, important to America," Rose added.
For more Health articles, visit www.foxnews.com/health
In 2022, California became the first state to mandate later school start times, with middle schools starting no earlier than 8 AM and high schools starting no earlier than 8:30 AM, according to the National Education Association (NEA).
Florida passed similar legislation in 2023, signed by Gov. Ron DeSantis. Beginning in 2026, public schools are to start no earlier than 8:30 AM for high schools and 8 AM for middle schools, the American Academy of Sleep Medicine reported.
A new bill (SB 296) filed in January by Sen. Jennifer Bradley, R-Fleming Island, seeks to undo these start times before they take effect next year.
Supporters in favor of later start times feel it improves student focus and health, while those not in favor argue that it will impact working parents and conflict with after-school activities, FOX 35 Orlando reported.
"Still, later school start times can have ripple effects in school districts and the impact will not be felt equally by all students, families and educators. Addressing these potential drawbacks and listening to all stakeholders is critical, experts say, before districts take this step," the NEA's site states.
The NEA reported that a 2021 University of Minnesota study focused on 18,000 students in grades 5 through 11 showed grade point averages increased by 0.1 points, on average, after school start times were pushed.
"While the researchers categorized the sleep benefits as 'large,' the academic improvements were considered 'small,'" the NEA wrote.
A 2022 study published in the Journal of School Health said students in Colorado "felt less stressed and more rested three years after high schools started 70 minutes later and middle schools began 40-to-60 minutes later," according to the same source.
"Later start time initiatives focus on middle and high school students because that is the age group more susceptible to the ill effects of inadequate sleep."
Fox News Digital reached out to "Start Schools Later" for comment.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
41 minutes ago
- Yahoo
NeuroSigma Announces Notice of Allowance for Patent Protecting Monarch eTNS System in China
LOS ANGELES, June 10, 2025 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company commercializing the Monarch external Trigeminal Nerve Stimulation (eTNS) device for treating attention-deficit hyperactivity disorder (ADHD), today announced a notice of allowance in China for a patent protecting the Monarch eTNS System. The patent, titled Pulse Generator for Trigeminal Nerve Stimulation, protects certain embodiments of NeuroSigma's core eTNS technology, including its second-generation Monarch device. The patent was allowed by China's National Intellectual Property Administration on May 27, 2025. In 2022, NeuroSigma licensed rights to the Monarch eTNS System for treating ADHD in China to Ignis Therapeutics, a leader in the development of novel therapeutics for central nervous system (CNS) conditions. 'As NeuroSigma continues to grow and work with our partners at Ignis, China will be a critical market for the Monarch eTNS System,' said Colin Kealey, M.D., President and CEO of NeuroSigma. 'This patent protects our second-generation Monarch device in China and significantly strengthens the company's intellectual property position.' "NeuroSigma's Monarch eTNS System is a highly innovative and effective therapy for ADHD,' added Tom Paschall, Director of NeuroSigma and CEO of Checkmate Capital. 'China is one of the largest and most important markets in the world for new CNS therapies. With this patent award, the Monarch device will benefit from robust intellectual property protection, which, we believe, will facilitate commercialization in this key market.' About NeuroSigma NeuroSigma is a Los Angeles, California-based bioelectronic medical device company developing technologies to transform medical practice and patients' lives. The company's lead product is the Monarch eTNS System, which is the first non-drug treatment for pediatric ADHD cleared by the FDA. Pipeline indications for the Monarch eTNS System include neurodevelopmental disorders such as autism spectrum disorder (ASD), learning disabilities, and epilepsy. NeuroSigma has received Breakthrough Device Designation for the Monarch eTNS System from the FDA in drug-resistant epilepsy. For more information about NeuroSigma, please visit For more information on the Monarch eTNS System, please visit Contact:Colin Kealey, M.D., President of NeuroSigma at CKealey@

Associated Press
an hour ago
- Associated Press
LUNG CANCER RESEARCH FOUNDATION EXPANDS RESEARCH ADVOCATES
Volunteers provide patient and caregiver perspective to foundation's grant award process NEW YORK, June 10, 2025 /PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) is pleased to announce the expansion of its Research Advocates. This select group of volunteers are patients, survivors, caregivers, healthcare professionals, and advocates committed to identifying and funding innovative lung cancer research. This group plays a vital role in shaping LCRF's research priorities by helping to identify funding areas, draft requests for proposals (RFPs), review and provide feedback on grant applications, and support efforts in education, awareness, and fundraising. 'Patient involvement in LCRF's research grant process is a critical component to identifying areas of unmet need and helping to identify the most promising projects to fund,' remarked Dr. Antoinette Wozniak, LCRF's Chief Scientific Officer. 'With their lived experience and input, they ensure that we are investing in projects that have the greatest chance of making an impact on lung cancer and patient outcomes.' 'As a lung cancer survivor, I have experienced firsthand how vital research is—not just in developing new treatments, but in giving me hope for the future,' said Maggie McCloskey, a new LCRF Research Advocate. 'Advances in targeted therapies and immunotherapy have extended lives and improved quality of life for people like me. Research is not just about science—it is about creating more tomorrows for patients and their families. As a research advocate, I am proud to help bring that hope to others through research funded by the Lung Cancer Research Foundation.' 'I joined LCRF as a Patient Research Advocate because our voices are vital in shaping research that truly reflects the needs of patients. We are the ones living with the disease, and our experiences can drive more meaningful, patient-centered solutions that improve care and outcomes for everyone facing lung cancer,' remarked Sydney Barned, MD. LCRF's Research Advocates: New Members (2025) Sydney Barned, MD – Annapolis, MD Internal Medicine Physician & Hospitalist Lung Cancer Patient/Survivor & Advocate Terri Ann DiJulio – West Chester, PA Lung Cancer Patient/Survivor & Advocate Catherine Doliente – Houston, TX Lung Cancer Patient/Survivor & Advocate Deborah H. Friedman – Piermont, NY Retired Publicist Lung Cancer Survivor and Advocate Stephanie Kaiser CRNP, AOCNP – Pittsburgh, PA Thoracic Oncology and Hospice Nurse Practitioner, Board member, Libby's Lungs Lung Cancer Patient/Survivor & Advocate Matthew Koebbe – Madison, AL IASLC Patient Research Advocate Lung Cancer Patient/Survivor & Advocate Maggie McCloskey – Moraga, CA Lung Cancer Patient/Survivor & Advocate Tillman Nechtman – Saratoga Springs, NY Professor of History at Skidmore College Former Caregiver Tejal Patel, PharmD, MHA, BCPS – Chicago, IL Vice President, Operations - Sinai Chicago Lung Cancer Patient/Survivor & Advocate Emily Walthall – Brevard, NC RETpositive Board Co-Chair Lung Cancer Patient/Survivor & Advocate Existing Members: Caroline Blanchard, DNP, FNP-C – Metairie, LA Urologic Oncology Nurse Practitioner Lung Cancer Patient/Survivor & Advocate Colleen Conner Ziegler — Rochester, NY LCRF Board of Directors, LCRF Scientific Executive Committee Lung Cancer Patient/Survivor & Advocate Denise Cutlip – Ypsilanti, MI LCRF Education and Engagement Committee Lung Cancer Patient/Survivor & Advocate Dusty J. Donaldson — High Point, NC Founder, Dusty Joy Foundation Lung Cancer Patient/Survivor & Advocate Bruce C. Dunbar — New Rochelle, NY LCRF Board of Directors and Scientific Advisory Board member Lung Cancer Patient/Survivor & Advocate Stephen Huff – College Grove, TN Founder of The Huff Project Lung Cancer Patient/Survivor & Advocate Tiffini Joseph, BSN, RN, CCRN – Pembroke Pines, FL Pediatric CVICU, Joe DiMaggio Children's Hospital Lung Cancer Patient Advocate Kristen H. Kimball, MS, MEM — Boston, MA Educator, UCONN Lung Cancer Patient Advocate and Former Caregiver Barbara LaMonaca — Falls Church, VA BSN, Speech Pathology & Audiology, Retired Lung Cancer Patient/Survivor & Advocate Barbara Marsh, DSW, MSW – Miamisburg, OH Social Worker Caregiver/Lung Cancer Patient Advocate Frank McKenna, MS Ed — Virginia Beach, VA Cancer Exercise Specialist Founder, Beach Better Bodies Lung Cancer Patient/Survivor & Advocate Aileen Murgatroyd – Yorkshire, UK Lung Cancer Patient Advocate Emily Venanzi, PhD — Newton, MA ALK Positive Inc. Medical Committee Lung Cancer Patient/Survivor & Advocate Marc Tannenbaum, MD – New York, NY Caregiver/Lung Cancer Patient Advocate Randi Warren, MD – New York, NY Lung Cancer Patient/Survivor & Advocate About the Lung Cancer Research Foundation (LCRF) The Lung Cancer Research Foundation® (LCRF) is the leading nonprofit organization focused on funding innovative, high-reward research with the potential to extend survival and improve quality of life for people with lung cancer. LCRF's mission is to improve lung cancer outcomes by funding research for the prevention, diagnosis, treatment, and cure of lung cancer. To date, LCRF has funded 429 research grants, totaling nearly $48 million, the highest amount provided by a nonprofit organization dedicated to funding lung cancer research. For more information, visit Contact: Sheila Sullivan, Sr. Director, Marketing & Communications [email protected] View original content to download multimedia: SOURCE Lung Cancer Research Foundation


The Onion
an hour ago
- The Onion
CDC Publishes Female Body Hair Guidelines
ATLANTA—Stressing that the rules were formulated for the safety of all Americans, the Centers for Disease Control and Prevention released new guidelines Thursday governing female body hair. 'Effective immediately, women nationwide are advised to remove all hair from arms, legs, underarms, and genital areas or suffer the legal consequences,' said CDC spokesperson Jamie Reardon, stressing that failure to comply with the newly issued weekly waxing schedule for women 18 and over would result in a $50 fine for every hair spotted that was over a millimeter long. 'Even so much as a thin landing strip or faint peach fuzz on the cheeks should be reported to authorities. That is, unless the woman in question has written approval from a male family member. But why would they do that? It's true that body hair doesn't cause diseases, per se. But it does look very gross.' This reportedly represents the first significant revisions to U.S. female body hair guidelines since 1977, when CDC director David Sencer urged all women to grow a full and unapologetic bush.